| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 47 |
| 1 | RITUXIMAB | 46 |
| 2 | PREDNISOLONE | 26 |
| 3 | PREDNISOLONE ORAL | 26 |
| 4 | PREDNISOLONE ORAL SOLUTION | 26 |
| 5 | TACROLIMUS | 20 |
| 6 | MYCOPHENOLATE MOFETIL | 19 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 19 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 19 |
| 9 | TACROLIMUS OINTMENT 0.1% | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLEMASTINE FUMARATE | 7 | 0.0050 |
| 1 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 2 | OBINUTUZUMAB | 15 | 0.0009 |
| 3 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 4 | OCRELIZUMAB | 47 | 0.0007 |
| 5 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 6 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 7 | SILVER SULFADIAZINE | 1 | 0.0004 |
| 8 | CLADRIBINE | 4 | 0.0004 |
| 9 | PATISIRAN | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 98 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 3 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 4 | beta3-Adrenergic Agonist [EPC] | 10 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 6 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 16 | 0.0002 |
| 7 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 8 | Tetracycline-class Drug [EPC] | 11 | 0.0002 |
| 9 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |